President Bush Fulfills Commitment To Doubling NIH Funding

[antiquity]

HHS: President Bush Fulfills Commitment To Doubling NIH Funding


WASHINGTON, Jan. 26 /U.S. Newswire/ -- President Bush will fulfill his commitment to a five-year plan to double the budget of the National Institutes of Health (NIH) when he submits his fiscal year 2003 budget proposal to Congress next month, HHS Secretary Tommy G. Thompson announced today.

The President's fiscal year 2003 budget proposal for NIH would increase its budget to $27.3 billion, an increase of $3.7 billion, the largest one-year increase ever for NIH. The proposal represents a growth of nearly 16 percent over the $23.6 billion allotted to NIH for fiscal year 2002. In fiscal year 1998, the NIH budget stood at $13.6 billion. President Bush had joined in a bipartisan commitment to doubling the 1998 level.

"The President could not be clearer about his commitment to medical research, the scientific enterprise and the value of NIH and its work," said Secretary Thompson. "The proposed NIH budget will support nearly 36,000 research project grants, an all-time record for the agency."

The allocation of the fiscal year 2003 NIH budget by institute and research area reflects both the professional judgments of the scientific leadership at NIH and challenges presented by the threat of bioterrorism.

Of the overall $3.7 billion increase over fiscal year 2002, approximately $1.5 billion would be devoted to proposed bioterrorism research, a five-fold increase over the $300 million budgeted for the previous fiscal year. After September 11, NIH leadership made a recommendation to HHS and the White House for significant expansion in bioterrorism related research. NIH's plan includes expansions in basic research, such as sequencing the genome of potential bioterrorism agents; accelerating development of next-generation anthrax vaccines; and improving diagnostic tools.

Cancer-related research would also be a priority under the President's proposal, reflecting growing opportunities in the fight against the nation's second leading killer. Cancer-related spending would increase from $4.9 billion in fiscal year 2002 to $5.5 billion in fiscal year 2003, an increase of nearly 13 percent, which is similar to the increase in cancer-related spending in fiscal year 2002. Other disease areas including diabetes, HIV/AIDS, Alzheimer's disease and Parkinson's disease will also receive substantial increases in the fiscal year 2003 budget.

"This research budget reflects the priority the administration places on a long-term solution to the bioterrorism threat, while fully recognizing the need to pursue a wealth of other important research opportunities," Secretary Thompson said.

Contact: HHS Press Office, 202-690-6343; Web site: http://www.hhs.gov/news

[angel7]

A lot of good an increase in NIH funds is going to do given Bush and his administration are going to make it a crime to research therapeutic cloning, stem cell research, etc. Also, you'll note that SCI research is not mentioned in the article. Gee thanks a lot Pres.

[This message was edited by Debbie7 on January 29, 2002 at 04:14 PM.]

[X-racer...]

NATIONAL INSTITUTES OF HEALTH
Research Initiatives/Programs of Interest
Use this link for single page, printable version of this table
(Dollars in millions) FY2000 FY2001 FY 2002
Research/Disease Areas Actual Estimate Estimate
Aging Research 1,468.8 1,660.7 1,846.7
AIDS (Budget Authority) 2,004.4 2,243.4 2,501.4
Minority AIDS 394.2 444.7 495.0
Pediatric AIDS 230.4 253.0 279.6
Vaccines AIDS 232.1 281.7 356.6
ALS 15.4 16.9 18.6
Alzheimer's Disease 456.3 520.7 582.7
Arthritis Research 268.9 304.6 340.0
Asthma 165.0 185.5 207.9
Autism 51.7 58.7 65.7
Autoimmune Disease 435.3 483.8 535.8
Behavioral and Social Science 1,849.6 2,083.0 2,329.2
Bioengineering 633.6 703.2 779.0
Bioterrorism 43.0 49.7 92.7
Brain Disorders 3,454.6 3,924.1 4,400.7
Cancer Research 3,854.4 4,351.8 4,866.1
Breast Cancer 536.0 571.6 629.7
Lung Cancer 192.0 208.1 228.2
Ovarian Cancer 78.6 84.4 92.6
Prostate Cancer 256.7 320.1 353.3
Cardiovascular Research 1,523.6 1,720.9 1,900.6
Chronic Fatigue Syndrome 5.8 6.2 6.6
Clinical Research 5,717.3 6,456.1 7,238.8
Complementary and Alternative Medicine 170.6 192.3 221.4
Cystic Fibrosis 81.2 91.5 102.2
Diabetes Research* 540.7 690.1 767.9
Diagnostic Radiology 399.2 438.8 477.5
Emerging Infectious Diseases 184.2 211.4 238.9
Fibromyalgia 10.7 12.3 13.7
Gene Therapy 424.2 476.4 530.2
Hepatitis - C 66.5 78.3 88.9
Hypertension 243.9 273.1 302.0
Infant Mortality/ (LBW) 399.1 452.2 510.4
Kidney Disease 277.2 315.6 353.3
Lupus 54.6 63.2 71.4
Mental Health 1,277.6 1,443.9 1,613.9
Multiple Sclerosis 61.9 69.0 76.8
Muscular Dystrophy 12.6 14.3 15.9
Neurosciences Research 3,341.0 3,796.3 4,259.8
Nutrition 665.2 745.9 828.9
Obesity 199.6 226.2 250.4
Osteoporosis 153.7 170.6 188.3
Parkinson's Disease 155.9 172.9 193.3
Pediatric Research 2,245.3 2,526.3 2,820.4
Polycystic Kidney Disease 15.2 17.4 19.5
Prevention 4,423.1 4,950.9 5,579.4
Schizophrenia 241.0 273.4 305.7
Sexually Transmitted Diseases/Herpes 144.4 162.3 181.7
Sickle Cell Disease 59.0 65.7 72.8
Sleep Disorders 123.9 140.7 156.5
Smoking and Health 379.7 427.6 486.0
Spinal Cord Injury 55.6 61.7 68.3
Stroke 215.3 238.5 262.9
Sudden Infant Death Syndrome 47.6 54.3 60.8
Topical Microbicides 30.5 35.1 41.1
Transmissible Spongiform Encephalopathy (TSE) 23.9 20.7 25.9
Tuberculosis Research 74.4 84.0 95.0
Vaccine Development 452.4 527.4 607.6
Women's Health 2,697.1 2,996.6 3,416.1
*Funds available for diabetes research in accordance with the Balanced Budget Act of 1997 (P.L. 105-33, FY 1998 through FY 2002) and P.L. 106-554 (FY 2001-2003). Of the amount available under P.L. 105-33, $3 million annually was transferred to the CDC and $27 million to the NIH. In fiscal year 2001, an additional $3.8 million was made available to the CDC from the diabetes funds managed by NIH. CDC is estimated to receive an additional $3.8M in FY 02 as well, although final allocations of the funds made available by P.L. 106-554 are to be determined. Allocations will be evaluated on an annual basis, and may be dependent on the quantity and quality of research proposals submitted.


I HOPE THIS COMES OUT OK, looks like SCI got a 10.7% raise.

LIVE IT UP AND LIVE IT LARGE!!!!

[bilby]

Debbie-

Maybe you should look again, it does mention spinal cord injuries.

After looking at that list it reminds me of a quote from Twain, "man is a home of impurities, a museum of diseases."

Thanks pres, you're doing a great job! http://sci.rutgers.edu/forum/images/smilies/smile.gif

bill

[antiquity]

Thanks, X-racer, I decided to organize the list in order of most funded to least funded for better clarity. Although neurosciences research is one of the top five funded areas, spinal cord injury, unfortunately, ranks at the bottom as one of the least funded.

1 Clinical Research 5,717.3 6,456.1 7,238.8
2 Prevention 4,423.1 4,950.9 5,579.4
3 Cancer Research 3,854.4 4,351.8 4,866.1
4 Brain Disorders 3,454.6 3,924.1 4,400.7
5 Neurosciences Research 3,341.0 3,796.3 4,259.8
6 Women's Health 2,697.1 2,996.6 3,416.1
7 Pediatric Research 2,245.3 2,526.3 2,820.4
8 AIDS (Budget Authority) 2,004.4 2,243.4 2,501.4
9 Behavioral and Social Science 1,849.6 2,083.0 2,329.2
10 Cardiovascular Research 1,523.6 1,720.9 1,900.6
11 Aging Research 1,468.8 1,660.7 1,846.7
12 Mental Health 1,277.6 1,443.9 1,613.9
13 Nutrition 665.2 745.9 828.9
14 Bioengineering 633.6 703.2 779.0
15 Diabetes Research* 540.7 690.1 767.9
16 Breast Cancer 536.0 571.6 629.7
17 Vaccine Development 452.4 527.4 607.6
18 Alzheimer's Disease 456.3 520.7 582.7
19 Autoimmune Disease 435.3 483.8 535.8
20 Gene Therapy 424.2 476.4 530.2
21 Infant Mortality/ (LBW) 399.1 452.2 510.4
22 Minority AIDS 394.2 444.7 495.0
23 Smoking and Health 379.7 427.6 486.0
24 Diagnostic Radiology 399.2 438.8 477.5
25 Vaccines AIDS 232.1 281.7 356.6
26 Prostate Cancer 256.7 320.1 353.3
27 Kidney Disease 277.2 315.6 353.3
28 Arthritis Research 268.9 304.6 340.0
29 Schizophrenia 241.0 273.4 305.7
30 Hypertension 243.9 273.1 302.0
31 Stroke 215.3 238.5 262.9
32 Obesity 199.6 226.2 250.4
33 Emerging Infectious Diseases 184.2 211.4 238.9
34 Lung Cancer 192.0 208.1 228.2
35 Complementary and Alternative Medicine 170.6 192.3 221.4
36 Asthma 165.0 185.5 207.9
37 Parkinson's Disease 155.9 172.9 193.3
38 Osteoporosis 153.7 170.6 188.3
39 Sexually Transmitted Diseases/Herpes 144.4 162.3 181.7
40 Sleep Disorders 123.9 140.7 156.5
41 Cystic Fibrosis 81.2 91.5 102.2
42 Tuberculosis Research 74.4 84.0 95.0
43 Bioterrorism 43.0 49.7 92.7
44 Ovarian Cancer 78.6 84.4 92.6
45 Hepatitis - C 66.5 78.3 88.9
46 Multiple Sclerosis 61.9 69.0 76.8
47 Sickle Cell Disease 59.0 65.7 72.8
48 Lupus 54.6 63.2 71.4
49 Spinal Cord Injury 55.6 61.7 68.3
50 Autism 51.7 58.7 65.7
51 Sudden Infant Death Syndrome 47.6 54.3 60.8
52 Topical Microbicides 30.5 35.1 41.1
53 Transmissible Spongiform Encephalopathy (TSE) 23.9 20.7 25.9
54 ALS 15.4 16.9 18.6
55 Muscular Dystrophy 12.6 14.3 15.9
56 Fibromyalgia 10.7 12.3 13.7
57 Chronic Fatigue Syndrome 5.8 6.2 6.6

[DA]

i wonder how the funding order was put in place. by population or by seriousness of ailment. why is sids and MD so far down? wasn't sickle cell cured in a boy 3 years ago using umbilical stem cells? wasn't sickle cell cured recently AGAIN using adult stem cells. then why isn't these cured passed around. oh wait, sickle cell researchers need a new building too.

[Wise Young]

seneca, thanks so much for putting this up. Wonderful analysis! I was in Washington discussing the budget at NIH just last week and they were totally mum about the budget.

DA, all the directors of NIH submit budget requests for what they think they can spend in the fall, this then goes through internal negotiations, the budget is then submitted to the Secretary of Health who forwards it to the Office of Management and Budget, and then finally the White House adjusts the budget to fit its priorities. The most important justification for a budgetary request is the number of good grants in a given subject that the NIH receives from investigators. Thus, if there are many very good grants getting high priority scores in a subject, a director of NIH can argue effectively for setting aside more money for that particular topic. Note that about a fourth of the budget is already committed to grants that have been awarded (the average grant award period of 4 years).

By the way, the above is one of the reasons why we have spent the last three years training over 100 laboratories to do better spinal cord injury research so that they can compete effectively for the funding. Since every grant is about $250,000 per year, 100 additional laboratories will be able to apply for $25 million additional grants.

Wise.